{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:24:49Z","timestamp":1770287089435,"version":"3.49.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Stroke"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:p>\n            <jats:bold>\n              <jats:italic>Background and Purpose\u2014<\/jats:italic>\n            <\/jats:bold>\n            Some strokes of unknown etiology may be the result of a paradoxical embolism traversing through a nonfused foramen ovale (patent foramen ovale [PFO]). The utility of percutaneously placed devices for treatment of patients with cryptogenic stroke or transient ischemic attack (TIA) and PFO is unknown. In addition, there are no clear data about the utility of medical interventions or other surgical procedures in this situation. Despite limited data, many patients are being treated with PFO closure devices. Thus, there is a strong need for clinical trials that test the potential efficacy of PFO occlusive devices in this situation. To address this gap in medical knowledge, we designed the CLOSURE I trial, a randomized, clinical trial comparing the use of a percutaneously placed PFO occlusive device and best medical therapy versus best medical therapy alone for prevention of recurrent ischemic neurologic symptoms among persons with TIA or ischemic stroke.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Study Design\u2014<\/jats:italic>\n            <\/jats:bold>\n            This prospective, multicenter, randomized, controlled trial has finished enrollment. Two-year follow-up for all 910 patients is required. The primary end point is the 2-year incidence of stroke or TIA, all-cause mortality for the first 30 days, and neurologic mortality from \u226531 days of follow-up, as adjudicated by a panel of physicians who are unaware of treatment allocation. This article describes the rationale and study design of CLOSURE I.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Conclusions\u2014<\/jats:italic>\n            <\/jats:bold>\n            This trial should provide information as to whether the STARFlex septal closure system is safe and more effective than best medical therapy alone in preventing recurrent stroke\/TIA and mortality in patients with PFO and whether the STARFlex septal closure device can demonstrate superiority compared with best medical therapy alone.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Clinical Trial Registration\u2014<\/jats:italic>\n            <\/jats:bold>\n            URL: http:\/\/www.clinicaltrials.gov. Unique identifier: NCT00201461.\n          <\/jats:p>","DOI":"10.1161\/strokeaha.110.593376","type":"journal-article","created":{"date-parts":[[2010,11,5]],"date-time":"2010-11-05T02:55:22Z","timestamp":1288925722000},"page":"2872-2883","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":47,"title":["Study Design of the CLOSURE I Trial"],"prefix":"10.1161","volume":"41","author":[{"given":"Anthony J.","family":"Furlan","sequence":"first","affiliation":[{"name":"From the University Hospitals (A.J.F.), Case Medical Center, Cleveland, Ohio; Swedish Medical Center (M.R.), Seattle, Wash; Harvard Clinical Research Institute (J.M., L.M.), Boston, Mass; University of Iowa (H.A.), Iowa City, Iowa; Stanford University Medical Center (G.W.A.), Palo Alto, Calif; Geisinger Medical Center (R.F.), Danville, Pa; University of Pennsylvania (H.H.), Philadelphia, Pa; Cedars Sinai Medical Center (S.K.), Los Angeles, Calif; Brigham and Women\u2019s Hospital (M.L.), Boston, Mass;..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Reisman","sequence":"additional","affiliation":[{"name":"From the University Hospitals (A.J.F.), Case Medical Center, Cleveland, Ohio; Swedish Medical Center (M.R.), Seattle, Wash; Harvard Clinical Research Institute (J.M., L.M.), Boston, Mass; University of Iowa (H.A.), Iowa City, Iowa; Stanford University Medical Center (G.W.A.), Palo Alto, Calif; Geisinger Medical Center (R.F.), Danville, Pa; University of Pennsylvania (H.H.), Philadelphia, Pa; Cedars Sinai Medical Center (S.K.), Los Angeles, Calif; Brigham and Women\u2019s Hospital (M.L.), Boston, Mass;..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Massaro","sequence":"additional","affiliation":[{"name":"From the University Hospitals (A.J.F.), Case Medical Center, Cleveland, Ohio; Swedish Medical Center (M.R.), Seattle, Wash; Harvard Clinical Research Institute (J.M., L.M.), Boston, Mass; University of Iowa (H.A.), Iowa City, Iowa; Stanford University Medical Center (G.W.A.), Palo Alto, Calif; Geisinger Medical Center (R.F.), Danville, Pa; University of Pennsylvania (H.H.), Philadelphia, Pa; Cedars Sinai Medical Center (S.K.), Los Angeles, Calif; Brigham and Women\u2019s Hospital (M.L.), Boston, Mass;..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Mauri","sequence":"additional","affiliation":[{"name":"From the University Hospitals (A.J.F.), Case Medical Center, Cleveland, Ohio; Swedish Medical Center (M.R.), Seattle, Wash; Harvard Clinical Research Institute (J.M., L.M.), Boston, Mass; University of Iowa (H.A.), Iowa City, Iowa; Stanford University Medical Center (G.W.A.), Palo Alto, Calif; Geisinger Medical Center (R.F.), Danville, Pa; University of Pennsylvania (H.H.), Philadelphia, Pa; Cedars Sinai Medical Center (S.K.), Los Angeles, Calif; Brigham and Women\u2019s Hospital (M.L.), Boston, Mass;..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harold","family":"Adams","sequence":"additional","affiliation":[{"name":"From the University Hospitals (A.J.F.), Case Medical Center, Cleveland, Ohio; Swedish Medical Center (M.R.), Seattle, Wash; Harvard Clinical Research Institute (J.M., L.M.), Boston, Mass; University of Iowa (H.A.), Iowa City, Iowa; Stanford University Medical Center (G.W.A.), Palo Alto, Calif; Geisinger Medical Center (R.F.), Danville, Pa; University of Pennsylvania (H.H.), Philadelphia, Pa; Cedars Sinai Medical Center (S.K.), Los Angeles, Calif; Brigham and Women\u2019s Hospital (M.L.), Boston, Mass;..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory W.","family":"Albers","sequence":"additional","affiliation":[{"name":"From the University Hospitals (A.J.F.), Case Medical Center, Cleveland, Ohio; Swedish Medical Center (M.R.), Seattle, Wash; Harvard Clinical Research Institute (J.M., L.M.), Boston, Mass; University of Iowa (H.A.), Iowa City, Iowa; Stanford University Medical Center (G.W.A.), Palo Alto, Calif; Geisinger Medical Center (R.F.), Danville, Pa; University of Pennsylvania (H.H.), Philadelphia, Pa; Cedars Sinai Medical Center (S.K.), Los Angeles, Calif; Brigham and Women\u2019s Hospital (M.L.), Boston, Mass;..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Felberg","sequence":"additional","affiliation":[{"name":"From the University Hospitals (A.J.F.), Case Medical Center, Cleveland, Ohio; Swedish Medical Center (M.R.), Seattle, Wash; Harvard Clinical Research Institute (J.M., L.M.), Boston, Mass; University of Iowa (H.A.), Iowa City, Iowa; Stanford University Medical Center (G.W.A.), Palo Alto, Calif; Geisinger Medical Center (R.F.), Danville, Pa; University of Pennsylvania (H.H.), Philadelphia, Pa; Cedars Sinai Medical Center (S.K.), Los Angeles, Calif; Brigham and Women\u2019s Hospital (M.L.), Boston, Mass;..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard","family":"Herrmann","sequence":"additional","affiliation":[{"name":"From the University Hospitals (A.J.F.), Case Medical Center, Cleveland, Ohio; Swedish Medical Center (M.R.), Seattle, Wash; Harvard Clinical Research Institute (J.M., L.M.), Boston, Mass; University of Iowa (H.A.), Iowa City, Iowa; Stanford University Medical Center (G.W.A.), Palo Alto, Calif; Geisinger Medical Center (R.F.), Danville, Pa; University of Pennsylvania (H.H.), Philadelphia, Pa; Cedars Sinai Medical Center (S.K.), Los Angeles, Calif; Brigham and Women\u2019s Hospital (M.L.), Boston, Mass;..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saibal","family":"Kar","sequence":"additional","affiliation":[{"name":"From the University Hospitals (A.J.F.), Case Medical Center, Cleveland, Ohio; Swedish Medical Center (M.R.), Seattle, Wash; Harvard Clinical Research Institute (J.M., L.M.), Boston, Mass; University of Iowa (H.A.), Iowa City, Iowa; Stanford University Medical Center (G.W.A.), Palo Alto, Calif; Geisinger Medical Center (R.F.), Danville, Pa; University of Pennsylvania (H.H.), Philadelphia, Pa; Cedars Sinai Medical Center (S.K.), Los Angeles, Calif; Brigham and Women\u2019s Hospital (M.L.), Boston, Mass;..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Landzberg","sequence":"additional","affiliation":[{"name":"From the University Hospitals (A.J.F.), Case Medical Center, Cleveland, Ohio; Swedish Medical Center (M.R.), Seattle, Wash; Harvard Clinical Research Institute (J.M., L.M.), Boston, Mass; University of Iowa (H.A.), Iowa City, Iowa; Stanford University Medical Center (G.W.A.), Palo Alto, Calif; Geisinger Medical Center (R.F.), Danville, Pa; University of Pennsylvania (H.H.), Philadelphia, Pa; Cedars Sinai Medical Center (S.K.), Los Angeles, Calif; Brigham and Women\u2019s Hospital (M.L.), Boston, Mass;..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Raizner","sequence":"additional","affiliation":[{"name":"From the University Hospitals (A.J.F.), Case Medical Center, Cleveland, Ohio; Swedish Medical Center (M.R.), Seattle, Wash; Harvard Clinical Research Institute (J.M., L.M.), Boston, Mass; University of Iowa (H.A.), Iowa City, Iowa; Stanford University Medical Center (G.W.A.), Palo Alto, Calif; Geisinger Medical Center (R.F.), Danville, Pa; University of Pennsylvania (H.H.), Philadelphia, Pa; Cedars Sinai Medical Center (S.K.), Los Angeles, Calif; Brigham and Women\u2019s Hospital (M.L.), Boston, Mass;..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Wechsler","sequence":"additional","affiliation":[{"name":"From the University Hospitals (A.J.F.), Case Medical Center, Cleveland, Ohio; Swedish Medical Center (M.R.), Seattle, Wash; Harvard Clinical Research Institute (J.M., L.M.), Boston, Mass; University of Iowa (H.A.), Iowa City, Iowa; Stanford University Medical Center (G.W.A.), Palo Alto, Calif; Geisinger Medical Center (R.F.), Danville, Pa; University of Pennsylvania (H.H.), Philadelphia, Pa; Cedars Sinai Medical Center (S.K.), Los Angeles, Calif; Brigham and Women\u2019s Hospital (M.L.), Boston, Mass;..."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.108.191261"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.29.5.944"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.14.1.6337424"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410250410"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.31.10.2407"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(95)90212-0"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.5.1301"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.24.12.8248969"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)90662-9"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-117-6-461"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000017498.88393.44"},{"key":"e_1_3_2_12_2","first-page":"847","volume":"82","year":"1989","unstructured":"Lechat P, Lascault G, Mas JL. Prevalence of patent foramen ovale in young patients with ischemic cerebral complications. Arch Mal Coeur Vaiss. 1989; 82: 847\u2013852.","journal-title":"Arch Mal Coeur Vaiss"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011503"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(98)70332-1"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)92944-3"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)60336-X"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410130315"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.28.9.1702"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.33.3.706"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.10.044"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2008.08.018"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-9-200311040-00010"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000119173.15878.F3"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.113.10.e409"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011258"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.100.suppl_2.Ii-171"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.5.1162"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.28.12.2376"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1010-7940(97)01175-5"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.25.3.8128511"},{"key":"e_1_3_2_31_2","first-page":"57","volume":"15","year":"1999","unstructured":"Cujec B, Johnson DH. Prevention of recurrent cerebral ischemic events in patients with patent foramen ovale and cryptogenic strokes or transient ischemic attacks. Can J Cardiol. 1999; 15: 57\u201364.","journal-title":"Can J Cardiol"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(95)00288-9"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.86.6.1451261"},{"key":"e_1_3_2_34_2","first-page":"115","volume":"2","year":"2001","unstructured":"Butera G, Bini MR, Chessa M, Bedogni F, Onofri M, Carminati M. Transcatheter closure of patent foramen ovale in patients with cryptogenic stroke. Ital Heart J. 2001; 2: 115\u2013118.","journal-title":"Ital Heart J"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.82.3.300"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(96)90405-1"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(98)00650-X"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.7.1330"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.101.8.893"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.108.192218"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsb020987"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.30.6.1174"},{"key":"e_1_3_2_43_2","unstructured":"Brass L. Letter to FDA (unpublished). 2004."},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/biostatistics\/3.2.277"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1081\/BIP-200062293"}],"container-title":["Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/STROKEAHA.110.593376","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T14:01:55Z","timestamp":1715608915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/STROKEAHA.110.593376"}},"subtitle":["A Prospective, Multicenter, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the STARFlex Septal Closure System Versus Best Medical Therapy in Patients With Stroke or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale"],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["10.1161\/STROKEAHA.110.593376"],"URL":"https:\/\/doi.org\/10.1161\/strokeaha.110.593376","relation":{},"ISSN":["0039-2499","1524-4628"],"issn-type":[{"value":"0039-2499","type":"print"},{"value":"1524-4628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"2010-06-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-07-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-11-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}